Status:

COMPLETED

Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation

Lead Sponsor:

Montclair State University

Conditions:

Endothelial Dysfunction

Eligibility:

All Genders

18-50 years

Brief Summary

The investigators examined the effects on post-digestion brachial artery flow mediated dilation (FMD) and in vitro antioxidant capacity of 40% semolina flour replacement with sprouted chickpea flour.

Detailed Description

The purpose of the current study was to examine in-vitro and in-vivo effects of replacing 40% of semolina flour with sprouted chickpea flour for the use in pasta. Antioxidant capacity in-vitro was mea...

Eligibility Criteria

Inclusion

  • healthy adult

Exclusion

  • have diabetes mellitus, kidney disease, a history of cancer, cardiac issues, pulmonary disease, history of a stroke, obesity (for most people this means a body mass index greater than 30), or any life threatening chronic conditions.
  • food allergies relevant to wheat, gluten, chickpea, and pasta sauce.
  • are currently being treated for infectious mononucleosis, hepatitis, pneumonia, or other infectious diseases.
  • are unable or unwilling to refrain from recreational drug (marijuana, cocaine, etc.) or alcohol use during the 24 hours prior to your exercise session.
  • use nicotine products, or non-contraceptive hormonal therapy (birth control is okay).
  • are pregnant or trying to become pregnant.

Key Trial Info

Start Date :

March 2 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2017

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT03801486

Start Date

March 2 2016

End Date

May 1 2017

Last Update

October 30 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.